Upper extremity thrombosis in Behçet

Abstract

Behçet\'s disease (BD) is a systemic disease characterized by oral aphthosis, genital ulcers, ocular lesions and also gastrointestinal, musculoskeletal, neurological and vessel involvements may develop. Venous manifestations are more common than arterial involvement. Venous involvement often occurs in the veins of lower extremity. Upper extremity venous involvement is rare. In this paper we report a case of BH presenting with upper extremity superficial vein thrombosis.

Keywords

• Behçet\'s disease, upper extremity, superficial vein thrombosis

Behçet hastalığında üst ekstremite trombozu

Abstract

Behçet hastalığı (BH) tekrarlayan oral, genital ülser ve göz tutulumuyla karakterize, ayrıca eklem, nörolojik, gastrointestinal sistem ve damar tutulumunun da oluşabildiği sistemik bir hastalıktır. BH\' de venöz tutulum arteryel tutulumdan daha fazla görülmektedir. Venöz tutulum sıklıkla alt ekstremite venlerinde meydana gelir. Üst ekstremite venlerinde tutulum ise nadirdir. Bu yazıda üst ekstremite yüzeyel ven trombozu ile gelen BH olgusundan bahsedilecektir.

Keywords

• Behçet hastalığı, üst ekstremite, yüzeyel ven trombozu

References

1. Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet 1990;335:1078-1080.
2. Ceylan N, Bayraktaroglu S, Erturk SM, et al. Pulmonary and vascular manifestations of Behcet disease: imaging find- ings. AJR Am J Roentgenol 2010;194:158-164.
3. Lie JT. Vascular involvement in Behcet’s disease: arterial and venous vessels of all sizes. J Rheumatol 1992;19:341-343.
4. Kutlucan A, Tunc SE, Baltacı D, et al. Serum levels of TNF-α and osteoprotegerin and bone mineral density in patients with Behçet’s Disease. Dicle Medical Journal 2012;39:325- 330.
5. Calamia K, Schimer M, Melikoğlu M. Major vessel involve- ment in Behcet’s disease. Current Opinion in Rheuma 2005;17:1-8.
6. Filali-Ansary N, Tazi-Mezalak Z, Mohattane A. Behcet’s dis- ease-162 cases. Ann Med Interne 1999;150:656-657.
7. Masuda K, Inaba G, Misushima Y. A nation-wide survey of Behcet’ s disease in Japan. Jpn J Ophthalmol 1975;19:278- 285.
8. Uğurlu S, Melikoğlu M, Tasçılar K, et al. Behçet hastalığında büyük damar tutulumu: retrospektif çalışma. 9. Ulusal Ro- matoloji Kongresi, pp; 2008.

9. Ateş A, Aydıntuğ OT, Duzgun N. Behcet’ s disease present- ing as deep venous thrombosis and priapism. Clin Exp Rheumatol 2004;22:107-109.
10. Leiba M, Sidi Y, Gur H, et al. Behçet’s disease and throm- bophilia. Ann Rheum Dis 2001;60:1081-1085.
11. Zouboulis CC. Epidemiology of Adamantiades Behcet’s disease. In: Ziehurt M, Ohno S, eds. Immunology of Be- hcet’s disease, Amsterdam: Grafisch Produktiebedrijh Gorter, 2003:1-16.
12. Kural-Seyahi E, Fresko I, Seyahi N, et al. The long term mortality ve morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003;82:60-76.
13. Hatemi G, Silman A, Bang D, et al. EULAR recommenda- tions for the management of Behçet’s disease: a report of a task force of the European Standing Committee for Interna- tional Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2008;67:1656-1629.
14. Calamia K, Cohen MD. Large vessel involvement in Be- hcet’ s disease. 8. International congress on Behcet’s dis- ease, 1998, Italy.
15. Kaklamani VG, Kaklamanis PG. Treatment of Behcet’ s dis- ease-an update. Semin Arthritis Rheumatism 2001;30:299- 312.